BSE filing, NSE: SICAGEN. Summary written from the filing by ALFA Finder's alert engine.
Sicagen India Ltd: key numbers
- Share price
- ₹50.00
- Market cap
- ₹197.9 Cr
- Revenue (annual)
- ₹973.5 Cr
- Net profit (annual)
- ₹18.07 Cr
- P/E (TTM)
- 9.7×Sector 36.4×
- Promoter holding
- 61.13%+0.00% QoQ
- FII holding
- 2.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sicagen India Ltd
All →Sicagen India Board Meeting Date
Sicagen India will hold a board meeting on 2 November 2026 to approve unaudited results. Trading window stays closed until 48 hours after declaration.
Sicagen India Other Announcement
Sicagen India Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by regulatory filings.
Sicagen India Annual General Meeting
Sicagen India Ltd held its 22nd Annual General Meeting on September 17, 2026. The meeting transacted ordinary and special business as per the agenda.
Sicagen India Annual General Meeting
Sicagen India Limited issued a notice for its 22nd Annual General Meeting to be held on September 17, 2026, via video conferencing.
Sicagen India Annual General Meeting
Sicagen India Ltd has scheduled its 22nd Annual General Meeting for September 17, 2026. The meeting will be held via video conferencing to transact ordinary and special business.
- Value
- ₹0.01 Cr
Sicagen India Annual Report
Sicagen India Ltd has submitted its 22nd Annual Report for the financial year 2025-26. The report includes audited financial statements, directors' report, and corporate governance details.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.